Hence, the use of 3PO as a PFKFB3 inhibitor could assist (C)RT by reversing the metabolic state of tumor and endothelial cells, thereby promoting tumor vessel normalization (TVN) to improve oxygenation and radiotherapy efficacy. Here, PFKFB3 is linked to neoplasm.